Figure 1From: Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma Kaplan-Meier analysis of overall survival (OS) and progression free survival (PFS) of all 32 patients. Back to article page